BRTX vs REG · rev $401.0K vs P/E 34, $12.93B cap
BioRestorative Therapies Inc (BRTX) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
REG does not have a complete income-statement cache yet.
BRTX currently screens at market cap $10.2M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the BRTX and REG stock pages for the full models.
Not investment advice.